Genotypic and Phenotypic Characteristics of CRB1-Associated Retinal Dystrophies

Mutations in the CRB1 gene are associated with a spectrum of progressive retinal degeneration. Visual acuity survival analyses indicate that the optimal intervention window for subretinal gene therapy is within the first 2 to 3 decades of life.